Replies to post #80699 on Amarantus Bioscience Holdings Inc (AMBS)

[blackhawks]

"We intend to rely heavily on not-for-profit funding for certain indications in order to minimize shareholder dilution while maximizing patient benefit as we move MANF forward. The economies of scale created by having a single therapeutic candidate treat multiple diseases cannot be overstated, as development milestones in one area support further development in the others".

Amazing though that yet again an AMBS pps retreat accompanies a CEO Blog from Gerald.

There is absolutely nothing in his blog that could be construed as negative information regarding either present AMBS activities or near term prospects for additional news.

There are actually 3 salient points in Gerald's blog:

1.'Intentions' RE funding.

2. Economies of scale for a single therapeutic candidate to treat multiple diseases.

3. Cited examples of successful orphan drug strategies pursued by several companies.

The latter two points should be at least somewhat persuasive to those from whom AMBS is seeking funding.

I'm the very last one to claim association is causation, but the 'coincidence' of AMBS pps drops with Geralds's communications
has become.....predictable.

And it probably will be predictable right up until the time that........it isn't!

In other words announcements of a JV or of receipt of non-dilutive funding.